LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 56.71 | 770.25 | 5610 | 8001 | 0.7011 | 0.8004 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.94 | 770.25 | 6651 | 8444 | 0.7876 | 0.8665 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.94 | 770.25 | 5948 | 8444 | 0.7044 | 0.8071 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 61.16 | 770.25 | 6893 | 8892 | 0.7752 | 0.8608 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 61.16 | 770.25 | 6189 | 8892 | 0.6960 | 0.8048 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.39 | 770.25 | 7234 | 9326 | 0.7757 | 0.8637 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.39 | 770.25 | 6385 | 9326 | 0.6846 | 0.8001 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.61 | 770.25 | 7610 | 9736 | 0.7816 | 0.8698 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.61 | 770.25 | 6754 | 9736 | 0.6937 | 0.8098 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.83 | 770.25 | 7975 | 10078 | 0.7913 | 0.8777 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.83 | 770.25 | 6885 | 10078 | 0.6832 | 0.8048 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.05 | 770.25 | 8328 | 10413 | 0.7997 | 0.8845 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.05 | 770.25 | 7140 | 10413 | 0.6856 | 0.8089 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 72.27 | 770.25 | 8714 | 10730 | 0.8121 | 0.8934 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 72.27 | 770.25 | 7269 | 10730 | 0.6774 | 0.8052 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.50 | 770.25 | 9044 | 10991 | 0.8228 | 0.9008 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.50 | 770.25 | 7422 | 10991 | 0.6752 | 0.8053 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.75 | 770.25 | 9394 | 11262 | 0.8341 | 0.9084 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.75 | 770.25 | 7557 | 11262 | 0.6710 | 0.8041 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.98 | 770.25 | 9761 | 11518 | 0.8474 | 0.9169 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.98 | 770.25 | 7722 | 11518 | 0.6704 | 0.8052 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 81.20 | 770.25 | 10115 | 11766 | 0.8597 | 0.9246 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 81.20 | 770.25 | 7760 | 11766 | 0.6595 | 0.7992 | MN20160304_L02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 83.42 | 770.25 | 10515 | 12031 | 0.8739 | 0.9332 | MN20160304_L02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 83.42 | 770.25 | 7895 | 12031 | 0.6562 | 0.7984 | MN20160304_L02 | L04 |